Annual Report and Accounts

The report records consolidated revenue of 37,211 US$'000 from trial phosphate-concentrate sales in FY2025, while Elandsfontein marked a record January production month and remained in ramp-up. It describes ore variability and production challenges, alongside positive initial results from the Pink Ore wash plant and Nanophos as a newly identified product opportunity.